Archived Facts

Shares of Sucampo Pharmaceuticals continued climbing Wednesday morning, a day after the drug developer said regulators will conduct a faster review of its drug Amitiza as a possible treatment for constipation caused by opioid pain drugs.

Popular Posts:

Related Posts:

Leave a Reply